Roberto Rossotti

1.4k total citations
45 papers, 377 citations indexed

About

Roberto Rossotti is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Roberto Rossotti has authored 45 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 21 papers in Epidemiology and 15 papers in Hepatology. Recurrent topics in Roberto Rossotti's work include HIV/AIDS drug development and treatment (18 papers), Hepatitis C virus research (14 papers) and HIV/AIDS Research and Interventions (13 papers). Roberto Rossotti is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), Hepatitis C virus research (14 papers) and HIV/AIDS Research and Interventions (13 papers). Roberto Rossotti collaborates with scholars based in Italy, United States and Israel. Roberto Rossotti's co-authors include Massimo Puoti, Giovanna Travi, Chiara Baiguera, Enrica Morra, Anna Orani, Marco Merli, Raffaele Bruno, Stefano Rusconi, Fabrizio Colombo and Michele Mondino and has published in prestigious journals such as Journal of Hepatology, AIDS and Clinical Microbiology and Infection.

In The Last Decade

Roberto Rossotti

39 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Rossotti Italy 9 190 174 151 63 55 45 377
Giovanna Travi Italy 11 174 0.9× 218 1.3× 106 0.7× 76 1.2× 19 0.3× 27 418
Laura Cardeñoso Spain 12 176 0.9× 256 1.5× 33 0.2× 35 0.6× 44 0.8× 26 415
Ingrid Steffen Switzerland 9 146 0.8× 233 1.3× 90 0.6× 16 0.3× 76 1.4× 15 418
Enzo Raise Italy 11 138 0.7× 205 1.2× 93 0.6× 13 0.2× 73 1.3× 27 369
Patrizia Caligiuri Italy 10 117 0.6× 177 1.0× 131 0.9× 13 0.2× 34 0.6× 20 299
Rafael Rodrı́guez-Rosado Spain 10 330 1.7× 523 3.0× 455 3.0× 14 0.2× 138 2.5× 17 732
Gaetano Maffongelli Italy 13 263 1.4× 162 0.9× 52 0.3× 46 0.7× 85 1.5× 29 427
Bo Tu China 12 90 0.5× 138 0.8× 85 0.6× 28 0.4× 60 1.1× 48 415
Álvaro Mena Spain 12 241 1.3× 334 1.9× 337 2.2× 7 0.1× 120 2.2× 52 551
Angiola Spinetti Italy 12 358 1.9× 711 4.1× 758 5.0× 25 0.4× 82 1.5× 21 949

Countries citing papers authored by Roberto Rossotti

Since Specialization
Citations

This map shows the geographic impact of Roberto Rossotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Rossotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Rossotti more than expected).

Fields of papers citing papers by Roberto Rossotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Rossotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Rossotti. The network helps show where Roberto Rossotti may publish in the future.

Co-authorship network of co-authors of Roberto Rossotti

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Rossotti. A scholar is included among the top collaborators of Roberto Rossotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Rossotti. Roberto Rossotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Travi, Giovanna, Alessandra Bielli, Elisa Matarazzo, et al.. (2025). Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection Control. Microorganisms. 13(4). 822–822.
2.
Vito, Andrea De, Alessandro Tavelli, Alessandro Cozzi‐Lepri, et al.. (2025). Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort. HIV Medicine. 26(6). 970–977.
3.
Rossotti, Roberto, Angelo Roberto Raccagni, Federico D’Amico, et al.. (2025). Attitudes and prescribing practices on doxycycline postexposure prophylaxis (DoxyPEP) among Italian infectious diseases physicians: findings from a National SIMIT Survey. Sexually Transmitted Infections. 102(2). 103–106.
4.
Rossotti, Roberto, Chiara Baiguera, Elena Di Gennaro, et al.. (2025). Patterns and Correlates of Initiation of Long-Acting Injectable Cabotegravir for Preexposure Prophylaxis: A Case-Control Analysis. Sexually Transmitted Diseases. 53(3). 183–186.
5.
Rossotti, Roberto, Alessandro Tavelli, Anna De Bona, et al.. (2024). Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition. AIDS and Behavior. 28(7). 2258–2263. 2 indexed citations
6.
Taramasso, Lucia, Roberto Rossotti, Alessandro Tavelli, et al.. (2024). Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 98(4). 352–356. 1 indexed citations
7.
Rossotti, Roberto, Alessandro Tavelli, Anna De Bona, et al.. (2024). Performance evaluation of a self-administered point-of-care test for anal HPV screening in PrEP users: data from a community-based PrEP service. Sexually Transmitted Infections. 100(4). 252–255.
8.
Monforte, Antonella d’Arminio, Alessandro Tavelli, Roberto Rossotti, et al.. (2023). Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort. Liver International. 43(10). 2130–2141. 1 indexed citations
9.
Rossotti, Roberto, Massimo Cernuschi, Federico D’Amico, et al.. (2023). Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective Analysis. Pathogens. 12(6). 798–798. 5 indexed citations
10.
Rossotti, Roberto, et al.. (2023). A case of chronic bacterial prostatitis due toMycoplasma genitalium. Sexually Transmitted Infections. 99(8). 571–573. 1 indexed citations
11.
Monforte, Antonella d’Arminio, Alessandro Tavelli, Romina Salpini, et al.. (2023). Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort. Liver International. 44(2). 603–613. 2 indexed citations
12.
Rossotti, Roberto, Alessandro Tavelli, Anna De Bona, et al.. (2023). Impact of COVID Pandemic on Sexual Habits and Pre-exposure Prophylaxis Retention in Care in a Community-Based Service. Sexuality Research and Social Policy. 20(4). 1592–1598. 1 indexed citations
13.
Rossotti, Roberto, Giovanna Travi, Nicola Ughi, et al.. (2020). Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis. Journal of Infection. 81(4). e11–e17. 83 indexed citations
14.
Rossotti, Roberto, Alessandro Tavelli, Stefano Bonora, et al.. (2020). Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts. Digestive and Liver Disease. 52(4). 447–451. 1 indexed citations
15.
Puoti, Massimo, et al.. (2014). Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs. Digestive and Liver Disease. 46. S206–S211. 10 indexed citations
16.
Puoti, Massimo, et al.. (2013). Optimizing treatment in HIV/HCV coinfection. Digestive and Liver Disease. 45. S355–S362. 12 indexed citations
17.
Puoti, Massimo, et al.. (2011). Hepatocellular carcinoma in HIV hepatitis C virus. Current Opinion in HIV and AIDS. 6(6). 534–538. 18 indexed citations
18.
Adorni, Fulvio, et al.. (2011). Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results. Current HIV Research. 9(8). 625–629. 2 indexed citations
19.
Franzetti, Marco, Michela Violin, Giovanni Casazza, et al.. (2011). Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy. Clinical Microbiology and Infection. 18(3). E66–E70. 5 indexed citations
20.
Foglieni, Barbara, Daniel Candotti, I. Guarnori, et al.. (2010). A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion. 51(4). 719–730. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna Travi Breakdown of academic impact, for papers by Laura Cardeñoso Breakdown of academic impact, for papers by Ingrid Steffen Breakdown of academic impact, for papers by Enzo Raise Breakdown of academic impact, for papers by Patrizia Caligiuri Breakdown of academic impact, for papers by Rafael Rodrı́guez-Rosado Breakdown of academic impact, for papers by Gaetano Maffongelli Breakdown of academic impact, for papers by Bo Tu Breakdown of academic impact, for papers by Álvaro Mena Breakdown of academic impact, for papers by Angiola Spinetti
Rankless by CCL
2026